Comparing upfront surgery and chemotherapy followed by surgery for oral cancer
Official title: Upfront Surgery Vs Induction Chemotherapy Followed By Surgery In Oral Cavity Squamous Cell Cancers With Advanced Nodal Disease (SurVIC Trial): A Phase 3 Multicentric Randomized Controlled Trial
Run by All India Institute of Medical Sciences, Jodhpur · NCT06737822 · Data updated 2026-11-12
This study is testing if starting with chemotherapy before surgery can help people with advanced oral cancer do better than having surgery right away.
Quick facts
| Phase | Phase 3 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years to 75 Years |
| Sex | All |
| Enrollment | 346 (estimated) |
| Sponsor | All India Institute of Medical Sciences, Jodhpur Government |
| Drugs / interventions | Chemotherapy |
| Locations | 7 sites (Bhubaneswar, Odisha and 6 other locations) |
| Status | Recruiting |
| Started | December 20, 2024 |
| Main results expected | October 2027 |
| Study ends | October 2029 |
| Registry record updated | March 4, 2025 |
| Trial ID | NCT06737822 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are newly diagnosed, treatment-naïve patients with biopsy-proven OSCC at clinical stages cT1-4a and cN2-N3.
✕Probably not a fit
Patients with distant metastases, significant weight loss, or those with certain comorbidities may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial aims to evaluate the effectiveness of induction chemotherapy followed by surgery in patients with advanced oral squamous cell carcinoma (OSCC) compared to immediate surgery. The study focuses on patients with clinically staged N2-N3 disease, who are typically at a higher risk for poor outcomes. By selecting a more homogeneous patient population, the trial seeks to determine if the addition of chemotherapy can improve oncological outcomes. The treatment regimen includes TPF or TPX chemotherapy followed by surgical intervention and adjuvant treatment.
Why it matters
Potential benefit: If successful, this approach could lead to improved survival rates and better treatment outcomes for patients with advanced oral cancer.
How similar studies have gone: Previous studies on neoadjuvant chemotherapy in head and neck cancers have shown mixed results, indicating that this approach is still being explored for its potential benefits.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Newly diagnosed, treatment naïve, biopsy or cytology proven OSCC * Clinical Stage cT1-4a, cN2-N3\*\*, M0- as per UICC 2018 * No evidence of distant metastases on chest x-ray and/or CT Thorax * ECOG PS 0-2 * No contraindication to Cisplatin or radiotherapy\*\*\* * Patients eligible for definitive curative intent treatment after discussion in multidisciplinary tumour board * Adequate organ function at time of participation, defined as Haematological: Haemoglobin \> 9gm/dl, ANC ≥ 1500/cmm3, Platelet ≥100000/cmm3 Liver Function test: Bilirubin ≤2 x upper limit normal (ULN), AST/ALT/ ALP ≤ 2.5 x ULN Renal Function test: Creatinine ≤ 1.5 ULN, Creatinine Clearance ≥60 ml/min. Exclusion Criteria: * Pregnant * History of moderate to severe hearing loss. * History of previous malignancy excluding non-melanoma skin cancers or cervical carcinoma in situ. * Documented Weight loss of more than 15% in the last 6 months. * Patients with known HIV, hepatitis B or C infection.
Where it's running
-
All India Institute of Medical Sciences, Jodhpur
Jodhpur, Rajasthan, India Recruiting -
All India Institute of Medical Sciences, Bhubaneshwar
Bhubaneswar, Odisha, India Not yet recruiting -
All India Institute of Medical Sciences, Bathinda
Bathinda, India Not yet recruiting -
Shri Mahant Indresh Hospital, Dehradun
Dehradun, India Not yet recruiting -
King George's Medical University
Lucknow, India Not yet recruiting -
All India Institute of Medical Sciences, Rishikesh
Rishikesh, India Not yet recruiting
Show 1 more location
-
Geetanjali Medical College, Udaipur
Udaipur, India Not yet recruiting
Study contacts
- Principal investigator: Dharma R Poonia, MS DNB — AIIMS Jodhpur
- Study coordinator: Dharma R Poonia, MS DNB
- Email: pooniadr@aiimsjodhpur.edu.in
- Phone: 9958654196
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Longer antibiotic prophylaxis after head and neck cancer surgery
This trial tests whether giving antibiotics for 7 days after major mouth and throat cancer surgery reduces wound infections compared with the standard 24-hour course.
-
Tai Chi during radiotherapy for head and neck cancer fatigue
This trial tests whether a 12-week Yang-style Tai Chi program added to usual care can reduce cancer-related fatigue in adults with head and neck cancer undergoing radiotherapy.
-
Topical Boswellia 2% Cream to Prevent Radiation Dermatitis in Head and Neck Cancer
A topical 2% Boswellia serrata cream is tested to see if it can prevent skin irritation from radiation in people with head and neck cancer.
-
Intratumoral fluorescent nivolumab before surgery in head and neck cancer
This study tests injecting fluorescently labeled nivolumab directly into head and neck tumors to see if it is safe and whether it reaches nearby lymph nodes before surgical removal.
-
Methylscape test in body fluids for multi-cancer detection in Colombia
A simple blood, urine, or saliva test called Methylscape is being tested to see if it can detect multiple cancers and identify where the signal is coming from, using people with cancer and healthy volunteers in Colombia.
-
Foot reflexology and ta-VNS for symptom relief in head and neck cancer during CCRT
This trial tests whether foot reflexology, transcutaneous auricular vagus nerve stimulation, and auricular acupressure can reduce pain, dry mouth, fatigue, and other symptoms for head and neck cancer patients receiving cisplatin-based chemoradiotherapy.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.